ArticleMolecular biology reports2021

Synergistic effect of metformin and vemurufenib (PLX4032) as a molecular targeted therapy in anaplastic thyroid cancer: an in vitro study.

Latha Durai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.